Nuedexta is indicated for the treatment of pseudobulbar affect (PBA) [1]. The recommended dosage for Nuedexta is one 20 mg capsule taken orally twice a day [1]. This dosage consists of 10 mg of dextromethorphan hydrobromide and 10 mg of quinidine sulfate [1].
How often should Nuedexta be taken?
Nuedexta is taken twice daily, in the morning and evening [1]. The medication should be administered as one capsule per dose [1].
What are the active ingredients in Nuedexta?
Nuedexta contains dextromethorphan hydrobromide and quinidine sulfate as its active ingredients [1]. Each capsule provides 10 mg of dextromethorphan and 10 mg of quinidine [1].
What is pseudobulbar affect (PBA)?
Pseudobulbar affect is a neurological disorder characterized by sudden, frequent, and involuntary episodes of crying or laughing that are incongruent with the patient's emotional state [1]. PBA can occur in individuals with underlying neurological conditions such as stroke, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), traumatic brain injury (TBI), and others [1].
Are there any dosage adjustments for Nuedexta?
Dosage adjustments are not typically required for Nuedexta based on age, gender, or kidney impairment [1]. However, healthcare providers consider individual patient responses and other medications when determining treatment [1]. Quinidine, one of the active ingredients, is a CYP2D6 inhibitor, which can affect the metabolism of other drugs [1].
Where can I find more information on Nuedexta?
More detailed information regarding Nuedexta's indication, dosage, and administration can be found on DrugPatentWatch.com [1].
Sources:
1. DrugPatentWatch.com